Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Heart surgery showdown: could a simple gas beat standard anesthesia?

NCT ID NCT07116733

First seen Jan 06, 2026 · Last updated Jun 22, 2026 · Updated 31 times

Summary

This study compares two anesthetics—desflurane gas and propofol—during coronary artery bypass surgery. Researchers want to see if desflurane helps prevent major heart problems like heart attack or heart failure within 30 days after surgery. About 3,560 adults having planned bypass surgery will take part.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIAC SURGERY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Cangzhou People's Hospital

    NOT_YET_RECRUITING

    Cangzhou, Hebei, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Changhai Hospital

    RECRUITING

    Shanghai, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Daping Hospital, Army Medical University

    NOT_YET_RECRUITING

    Chongqing, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Fuzhou University Affiliated Provincial Hospital

    NOT_YET_RECRUITING

    Fuzhou, Fujian, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Hebei General Hospital

    NOT_YET_RECRUITING

    Shijiazhuang, Hebei, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Jiangsu Province Hospital

    NOT_YET_RECRUITING

    Nanjin, Jiangsu, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Ningbo No.2 Hospital

    NOT_YET_RECRUITING

    Ningbo, Zhejiang, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Sichuan Provincial People's Hospital

    NOT_YET_RECRUITING

    Chengdu, Sichuan, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • The First Affiliated Hospital of Zhengzhou University

    NOT_YET_RECRUITING

    Zhengzhou, Henan, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • The First Hospital of Hebei Medical University

    NOT_YET_RECRUITING

    Shijiazhuang, Hebei, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Tianjin Chest Hospital

    RECRUITING

    Tianjin, Tianjin Municipality, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Wuhan Asia Heart Hospital

    NOT_YET_RECRUITING

    Wuhan, Hubei, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Xijing Hospital

    RECRUITING

    Xi'an, Shaanxi, 710032, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Zhongshan Hospital, Fudan University

    NOT_YET_RECRUITING

    Shanghai, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

desflurane (inhaled anesthetic)

What this could lead to

If desflurane works better than propofol, it could become the preferred anesthetic for heart bypass surgery to lower the risk of serious heart complications after the operation.

What could go wrong

This is a large phase 3 trial, but it's still possible that desflurane offers no advantage over propofol. The study focuses on short-term outcomes (30 days), so long-term benefits are unknown.

Conditions

The condition(s) this trial relates to.

coronary artery disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.